Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide

被引:1730
作者
Ren, Guangwen [1 ]
Zhang, Liying [1 ]
Zhao, Xin [1 ]
Xu, Guangwu [1 ]
Zhang, Yingyu [1 ]
Roberts, Arthur I. [1 ]
Zhao, Robert Chunhua [2 ,3 ,4 ]
Shi, Yufang [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100005, Peoples R China
[3] Chinese Acad Med Sci, Sch Bas Med, Beijing 100005, Peoples R China
[4] Peking Union Med Coll, Beijing 100005, Peoples R China
关键词
D O I
10.1016/j.stem.2007.11.014
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stem cells (MSCs) can become potently immunosuppressive through unknown mechanisms. We found that the immunosuppressive function of MSCs is elicited by IFN gamma and the concomitant presence of any of three other proinflammatory cytokines, TNF alpha, IL-1 alpha, or IL-beta. These cytokine combinations provoke the expression of high levels of several chemokines and inducible nitric oxide synthase (iNOS) by MSCs. Chemokines drive T cell migration into proximity with MSCs, where T cell responsiveness is suppressed by nitric oxide (NO). This cytokine-induced immunosuppression was absent in MSCs derived from iNOS(-/-) or IFN gamma R1(-/-) mice. Blockade of chemokine receptors also abolished the immunosuppression. Administration of wild-type MSCs, but not IFNyR1(-/-) or iNOS(-/-) MSCs, prevented graft-versus-host disease in mice, an effect reversed by anti-IFN gamma or iNOS inhibitors. Wild-type MSCs also inhibited delayed-type hypersensitivity, while iNOS(-/-) MSCs aggravated it. Therefore, proinflammatory cytokines are required to induce immunosuppression by MSCs through the concerted action of chemokines and NO.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 56 条
  • [1] Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal, S
    Pittenger, MF
    [J]. BLOOD, 2005, 105 (04) : 1815 - 1822
  • [2] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [3] Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves
    Batten, Puspa
    Sarathchandra, Padmini
    Antoniw, Joseph W.
    Tay, Szun Szun
    Lowdell, Mark W.
    Taylor, Patricia M.
    Yacoub, Magdi H.
    [J]. TISSUE ENGINEERING, 2006, 12 (08): : 2263 - 2273
  • [4] Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing
    Chamberlain, Giselle
    Fox, James
    Ashton, Brian
    Middleton, Jim
    [J]. STEM CELLS, 2007, 25 (11) : 2739 - 2749
  • [5] Mesenchymal stem cells in immunoregulation
    Chen, Xi
    Armstrong, Marilyn Ann
    Li, Gang
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (05) : 413 - 421
  • [6] The role of mesenchymal stem cells in haemopoiesis
    Dazzi, Francesco
    Ramasamy, Rajesh
    Glennie, Sarah
    Jones, Simon P.
    Roberts, Irene
    [J]. BLOOD REVIEWS, 2006, 20 (03) : 161 - 171
  • [7] Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells
    Devadas, Satish
    Das, Jyoti
    Liu, Catherine
    Zhang, Liying
    Roberts, Arthur I.
    Pan, Zui
    Moore, Paul A.
    Das, Gobardhan
    Shi, Yufang
    [J]. IMMUNITY, 2006, 25 (02) : 237 - 247
  • [8] Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis
    Djouad, F
    Fritz, V
    Apparailly, F
    Louis-Plence, P
    Bony, C
    Sany, J
    Jorgensen, C
    Noël, D
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (05): : 1595 - 1603
  • [9] New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes
    Edwards, T. M.
    Rickard, N. S.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03) : 413 - 425
  • [10] Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells
    Groh, ME
    Maitra, B
    Szekely, E
    Koç, ON
    [J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (08) : 928 - 934